News

Wireless Monitoring May Help Transition of Therapy in PAH, Study Suggests

An implantable wireless system may help guide the transition from medication administered intravenously — Remodulin (treprostinil) — to one taken orally — Uptravi (selexipag) — in the treatment of pulmonary arterial hypertension (PAH), according to a small study. The study, “Use of an implantable wireless pulmonary pressure monitor during…

Neurological Problems Possible in Premature Babies with BPD-related PH, Study Finds

Pulmonary hypertension (PH) is associated with poorer neurodevelopmental outcome and impaired growth in the first two years of life for preterm infants with bronchopulmonary dysplasia, a study shows. The study, “Developmental outcomes of preterm infants with bronchopulmonary dysplasia-associated pulmonary hypertension at 18-24 months of corrected age,” was published…